Achieve Life Sciences (ACHV) Other financing activities (2010 - 2026)

Achieve Life Sciences' Other financing activities history runs 13 years deep, the most recent figure standing at $21000.0 for Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, up 103.08% from the prior year.
• Other financing activities was $21000.0 for Q1 2026 at Achieve Life Sciences, down from $1.3 million in the prior quarter.
• Across five years, Other financing activities topped out at $56.1 million in Q1 2024 and bottomed at -$55.9 million in Q3 2024.
• A 5-year average of $194916.7 and a median of $89500.0 in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities slumped 10100.0% — and 2024, when it jumped 72770.13%.
• Achieve Life Sciences' Other financing activities stood at -$102000.0 in 2022, then jumped by 247.06% to $150000.0 in 2023, then surged by 236.0% to $504000.0 in 2024, then surged by 150.99% to $1.3 million in 2025, then sank by 98.34% to $21000.0 in 2026.
• Business Quant data shows ACHV's Other financing activities at $21000.0 in Q1 2026, $1.3 million in Q4 2025, and $120000.0 in Q3 2025.